Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib
Despoina Pantazi,1 Nikoleta Ntemou,2 Alexios Brentas,2 Dimitrios Alivertis,3 Konstantinos Skobridis,2 Alexandros D Tselepis1 1Department of Chemistry, Atherothrombosis Research Centre, Laboratory of Biochemistry, University of Ioannina, Ioannina 45110, Greece; 2Department of Chemistry, Section of Or...
Main Authors: | Pantazi D, Ntemou N, Brentas A, Alivertis D, Skobridis K, Tselepis AD |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/molecular-requirements-for-the-expression-of-antiplatelet-effects-by-s-peer-reviewed-article-DDDT |
Similar Items
-
Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro
by: Louisa Pechlivani, et al.
Published: (2024-03-01) -
Antiplatelet agents: an overview
by: Asma Haffouz, et al.
Published: (2023-01-01) -
Antiplatelet Aggregation Properties of Cirsilineol: A Novel Inhibitor of Blood Coagulation Factor Xa
by: Go Oun Kim, et al.
Published: (2023-04-01) -
Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia Cells
by: Katerina Arvaniti, et al.
Published: (2014-07-01) -
Antiplatelet and Antithrombotic Activity of a Traditional Medicine, Hwangryunhaedok-Tang
by: Kyungho Kim, et al.
Published: (2019-01-01)